Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2003210rdf:typepubmed:Citationlld:pubmed
pubmed-article:2003210lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:2003210lifeskim:mentionsumls-concept:C1859420lld:lifeskim
pubmed-article:2003210lifeskim:mentionsumls-concept:C0032134lld:lifeskim
pubmed-article:2003210pubmed:issue5lld:pubmed
pubmed-article:2003210pubmed:dateCreated1991-4-18lld:pubmed
pubmed-article:2003210pubmed:abstractTextIn 10 patients with Guillain-Barré syndrome the level of globulins and immunoglobulins before and after plasmapheresis was investigated. As a plasma substitute either PPL (in 8 patients) or a plasma substitute solution rich in immunoglobulins (in 2 patients) was used. When plasma was substituted with PPL, the globulins and immunoglobulins dropped to a mean of 40% of the initial value (range 30-60%) after the first plasmapheresis. With daily or alternate day plasmapheresis, the globulins only partially recovered. Before the second plasmapheresis they were still reduced to a mean of 50% (range 20-50%), and dropped further with ongoing exchanges to a mean of 33% (range 20-50%) as measured before the third plasmapheresis. Accordingly, there was a loss of immunoglobulins of similar magnitude. With the use of a plasma substitute solution rich in immunoglobulins (IRP), globulins could be maintained at normal levels. The lowest immunoglobulin values measured after plasmapheresis were 6 g/l (normal range 8-17 g/l). One patient developed gram-negative septicaemia after plasmapheresis with PPL, possibly due to a low immunoglobulin concentration. We conclude that a plasma substitute solution rich in immunoglobulins should be used for therapeutic plasmapheresis in order to maintain physiological immunoglobulin concentrations.lld:pubmed
pubmed-article:2003210pubmed:languagegerlld:pubmed
pubmed-article:2003210pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2003210pubmed:citationSubsetIMlld:pubmed
pubmed-article:2003210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2003210pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2003210pubmed:statusMEDLINElld:pubmed
pubmed-article:2003210pubmed:monthFeblld:pubmed
pubmed-article:2003210pubmed:issn0036-7672lld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:SpeckBBlld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:GratwohlAAlld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:TichelliAAlld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:DazziHHlld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:SteblerCClld:pubmed
pubmed-article:2003210pubmed:authorpubmed-author:WernliMMlld:pubmed
pubmed-article:2003210pubmed:issnTypePrintlld:pubmed
pubmed-article:2003210pubmed:day2lld:pubmed
pubmed-article:2003210pubmed:volume121lld:pubmed
pubmed-article:2003210pubmed:ownerNLMlld:pubmed
pubmed-article:2003210pubmed:authorsCompleteYlld:pubmed
pubmed-article:2003210pubmed:pagination145-9lld:pubmed
pubmed-article:2003210pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:meshHeadingpubmed-meshheading:2003210-...lld:pubmed
pubmed-article:2003210pubmed:year1991lld:pubmed
pubmed-article:2003210pubmed:articleTitle[Immunoglobulin deficiency after repeated plasmapheresis].lld:pubmed
pubmed-article:2003210pubmed:affiliationDepartement Innere Medizin, Kantonsspital Basel.lld:pubmed
pubmed-article:2003210pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2003210pubmed:publicationTypeEnglish Abstractlld:pubmed